Peer-reviewed articles

Hegarty JM, Wallace M, Comber H. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland. Am J Mens Health. 2008;2(2):133-142. doi:10.1177/1557988307300467

Drummond FJ, Sharp L, Carsin AE, Kelleher T, Comber H. Questionnaire order significantly increased response to a postal survey sent to primary care physicians. J Clin Epidemiol. 2008;61(2):177-185. doi:10.1016/j.jclinepi.2007.04.012

Donnelly M, Anderson LA, Johnston BT, et al. Oesophageal cancer: caregiver mental health and strain. Psychooncology. 2008;17(12):1196-1201. doi:10.1002/pon.1337

Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut. 2008;57(6):734-739. doi:10.1136/gut.2007.132662

Stack M, Walsh PM, Comber H, Ryan CA, O’Lorcain P. Childhood cancer in Ireland: a population-based study. Arch Dis Child. 2007;92(10):890-897. doi:10.1136/adc.2005.087544

Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8(9):784-796. doi:10.1016/S1470-2045(07)70246-2

Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 2007;8(9):773-783. doi:10.1016/S1470-2045(07)70245-0

Murphy SJ, Hughes AE, Patterson CC, et al. A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett’s esophagus and esophageal adenocarcinoma. Carcinogenesis. 2007;28(6):1323-1328. doi:10.1093/carcin/bgm007

Cronin-Fenton DP, Sharp L, Carsin AE, Comber H. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer. 2007;43(3):565-575. doi:10.1016/j.ejca.2006.10.011

O’Lorcain P, Walsh PM, Comber H. Cumulative cancer mortality risk and potential years of life lost to 64 years of age in Ireland, 1953-2002. EurJCancer Prev. 2007;16(3):167-177. doi:10.1097/01.cej.0000228408.68353.ba

O’Lorcain P, Comber H. Prostate cancer mortality predictions for Ireland up to 2015. Eur J Cancer Prev. 2007;16(4):328-333. doi:10.1097/01.cej.0000236248.63489.4c

Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13(10):1585-1594. doi:10.3748/wjg.v13.i10.1585

Sharp L, Miedzybrodzka Z, Cardy AH, et al. The C677T polymorphism in the methylenetetrahydrofolate reductase gene (MTHFR), maternal use of folic acid supplements, and risk of isolated clubfoot: A case-parent-triad analysis. Am J Epidemiol. 2006;164(9):852-861. doi:10.1093/aje/kwj285

Cronin-Fenton DP, Sharp L, Deady S, Comber H. Treatment and survival for non-Hodgkin’s lymphoma: influence of histological subtype, age, and other factors in a population-based study (1999-2001). Eur J Cancer. 2006;42(16):2786-2793. doi:10.1016/j.ejca.2006.04.018

Laing ME, Moloney FJ, Comber H, Conlon P, Murphy GM. Malignant melanoma in renal transplant recipients. Br J Dermatol. 2006;155(4):857. doi:10.1111/j.1365-2133.2006.07395.x

Walsh PM, McCarron P, Middleton RJ, Comber H, Gavin AT, Murray L. Influence of mammographic screening on trends in breast-conserving surgery in Ireland. Eur J Cancer Prev. 2006;15(2):138-148. doi:10.1097/01.cej.0000180668.96710.47

Moloney FJ, Comber H, Conlon PJ, Murphy GM. The role of immunosuppression in the pathogenesis of basal cell carcinoma. Br J Dermatol. 2006;154(4):790-791. doi:10.1111/j.1365-2133.2006.07156.x

Moloney FJ, Comber H, O’Lorcain P, O’Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol. 2006;154(3):498-504. doi:10.1111/j.1365-2133.2005.07021.x

O’Lorcain P, Comber H. Mortality predictions for Ireland, 2001-2015: cancers of the breast, ovary, and cervix and Corpus uteri. Int J Gynecol Cancer. 2006;16 Suppl 1:1-10. doi:10.1111/j.1525-1438.2006.00479.x

Sharp L, Cotton SC, Alexander L, et al. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears). Clin Trials. 2006;3(5):431-442. doi:10.1177/1740774506070812

O’Lorcain P, Deady S, Comber H. Mortality predictions for colon and anorectal cancer for Ireland, 2003-17. Colorectal Dis. 2006;8(5):393-401. doi:10.1111/j.1463-1318.2006.00951.x

O’Lorcain P, Deady S, Comber H. Mortality predictions for esophageal, stomach, and pancreatic cancer, Ireland, up to 2015. Int J Gastrointest Cancer. 2006;37(1):15-25. doi:10.1385/IJGC:37:1:15

Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66(9):4975-4982. doi:10.1158/0008-5472.CAN-05-4253

Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005;98(8):238-239.

Cronin DP, Harlan LC, Clegg LX, Stevens JL, Yuan G, Davis TA. Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin’s lymphoma. Hematol Oncol. 2005;23(2):73-81. doi:10.1002/hon.747